HomeSTIM • NASDAQ
add
Neuronetics Inc
Nakaraang pagsara
$1.71
Sakop ng araw
$1.76 - $2.56
Sakop ng taon
$0.52 - $5.07
Market cap
121.88M USD
Average na Volume
255.45K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 18.53M | 3.61% |
Gastos sa pagpapatakbo | 21.73M | 5.30% |
Net na kita | -13.34M | -42.06% |
Net profit margin | -72.00 | -37.12% |
Kita sa bawat share | -0.44 | -33.33% |
EBITDA | -7.17M | 13.99% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 20.87M | -41.79% |
Kabuuang asset | 74.12M | -20.29% |
Kabuuang sagutin | 64.74M | 17.60% |
Kabuuang equity | 9.38M | — |
Natitirang share | 30.35M | — |
Presyo para makapag-book | 5.52 | — |
Return on assets | -22.61% | — |
Return on capital | -27.58% | — |
Cash Flow
Net change in cash
| (USD) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -13.34M | -42.06% |
Cash mula sa mga operasyon | -5.42M | 46.49% |
Cash mula sa pag-invest | 14.00K | -78.79% |
Cash mula sa financing | -16.37M | — |
Net change in cash | -21.78M | -116.49% |
Malayang cash flow | -2.85M | 62.41% |
Tungkol
Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology.
Neuronetics became the "first and only Food and Drug Administration approval for the clinical treatment of a specific form of medication-refractory depression using a TMS Therapy device."
They manufacture a transcranial magnetic stimulation device, NeuroStar. The NeuroStar TMS therapy is delivered via a precisely positioned magnetic coil against the patient's head. Wikipedia
Itinatag
2003
Headquarters
Website
Mga Empleyado
201
